These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 23278211)

  • 1. In silico modeling for prediction of drug-induced adverse reactions and environmental hazards using QSAR tools.
    Saha A; Roy K
    Curr Drug Saf; 2012 Sep; 7(4):255-6. PubMed ID: 23278211
    [No Abstract]   [Full Text] [Related]  

  • 2. Toxicological and clinical computational analysis and the US FDA/CDER.
    Benz RD
    Expert Opin Drug Metab Toxicol; 2007 Feb; 3(1):109-24. PubMed ID: 17269898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. QSAR Modeling of ToxCast Assays Relevant to the Molecular Initiating Events of AOPs Leading to Hepatic Steatosis.
    Gadaleta D; Manganelli S; Roncaglioni A; Toma C; Benfenati E; Mombelli E
    J Chem Inf Model; 2018 Aug; 58(8):1501-1517. PubMed ID: 29949360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico toxicology for the pharmaceutical sciences.
    Valerio LG
    Toxicol Appl Pharmacol; 2009 Dec; 241(3):356-70. PubMed ID: 19716836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The importance of scaling in data mining for toxicity prediction.
    Mazzatorta P; Benfenati E; Neagu D; Gini G
    J Chem Inf Comput Sci; 2002; 42(5):1250-5. PubMed ID: 12377016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative structure-activity relationship models for predicting drug-induced liver injury based on FDA-approved drug labeling annotation and using a large collection of drugs.
    Chen M; Hong H; Fang H; Kelly R; Zhou G; Borlak J; Tong W
    Toxicol Sci; 2013 Nov; 136(1):242-9. PubMed ID: 23997115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computer-aided Drug Design and Drug Pharmacokinetic Prediction: A Mini-review.
    Tabeshpour J; Sahebkar A; Zirak MR; Zeinali M; Hashemzaei M; Rakhshani S; Rakhshani S
    Curr Pharm Des; 2018; 24(26):3014-3019. PubMed ID: 30179125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive QSAR modeling for the successful predictions of the ADMET properties of candidate drug molecules.
    Khan MT; Sylte I
    Curr Drug Discov Technol; 2007 Oct; 4(3):141-9. PubMed ID: 17985997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational toxicology: Its essential role in reducing drug attrition.
    Naven RT; Louise-May S
    Hum Exp Toxicol; 2015 Dec; 34(12):1304-9. PubMed ID: 26614820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In silico approaches to explore toxicity end points: issues and concerns for estimating human health effects.
    Matthews EJ; Contrera JF
    Expert Opin Drug Metab Toxicol; 2007 Feb; 3(1):125-34. PubMed ID: 17269899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent uses of topological indices in the development of in silico ADMET models.
    Votano JR
    Curr Opin Drug Discov Devel; 2005 Jan; 8(1):32-7. PubMed ID: 15679169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. QSAR Methods.
    Gini G
    Methods Mol Biol; 2016; 1425():1-20. PubMed ID: 27311459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicophore exploration as a screening technology for drug design and discovery: techniques, scope and limitations.
    Singh PK; Negi A; Gupta PK; Chauhan M; Kumar R
    Arch Toxicol; 2016 Aug; 90(8):1785-802. PubMed ID: 26341667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges and directions for regulatory use of QSARs for predicting active pharmaceutical ingredients environmental toxicity.
    Sanderson H
    Curr Drug Saf; 2012 Sep; 7(4):309-12. PubMed ID: 23062243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. QSAR without borders.
    Muratov EN; Bajorath J; Sheridan RP; Tetko IV; Filimonov D; Poroikov V; Oprea TI; Baskin II; Varnek A; Roitberg A; Isayev O; Curtarolo S; Fourches D; Cohen Y; Aspuru-Guzik A; Winkler DA; Agrafiotis D; Cherkasov A; Tropsha A
    Chem Soc Rev; 2020 Jun; 49(11):3525-3564. PubMed ID: 32356548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico methods for early toxicity assessment.
    Merlot C
    Curr Opin Drug Discov Devel; 2008 Jan; 11(1):80-5. PubMed ID: 18175270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative structure-activity relationship methods: perspectives on drug discovery and toxicology.
    Perkins R; Fang H; Tong W; Welsh WJ
    Environ Toxicol Chem; 2003 Aug; 22(8):1666-79. PubMed ID: 12924569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toward a unifying strategy for the structure-based prediction of toxicological endpoints.
    Carrió P; Sanz F; Pastor M
    Arch Toxicol; 2016 Oct; 90(10):2445-60. PubMed ID: 26553148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Troubleshooting computational methods in drug discovery.
    Kortagere S; Ekins S
    J Pharmacol Toxicol Methods; 2010; 61(2):67-75. PubMed ID: 20176118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehension of drug toxicity: software and databases.
    Toropov AA; Toropova AP; Raska I; Leszczynska D; Leszczynski J
    Comput Biol Med; 2014 Feb; 45():20-5. PubMed ID: 24480159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.